The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 346:752-763 March 7, 2002 Number 10
NextNext

The Antiphospholipid Syndrome
Jerrold S. Levine, M.D., D. Ware Branch, M.D., and Joyce Rauch, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Antiphospholipid antibodies are a family of autoantibodies that exhibit a broad range of target specificities and affinities, all recognizing various combinations of phospholipids, phospholipid-binding proteins, or both. The term "antiphospholipid syndrome" was first coined to denote the clinical association between antiphospholipid antibodies and a syndrome of hypercoagulability.1,2 Revision of the criteria for diagnosis of the antiphospholipid syndrome and the terminology used to describe the disease is an ongoing process3 (Table 1).

View this table:
[in this window]
[in a new window]
 
Table 1. International Consensus Statement on Preliminary Criteria for the Classification of the Antiphospholipid Syndrome.

 
Background

The first antiphospholipid antibody, a complement-fixing antibody that reacted with extracts from bovine hearts, . . . [Full Text of this Article]

Detection of Clinically Relevant Antiphospholipid Antibodies

Pathogenesis

Criteria for Classification and Diagnosis

Epidemiology

Differential Diagnosis

Clinical Features

Pathological Features

Obstetrical Considerations

Catastrophic Antiphospholipid Syndrome

Treatment

Prophylaxis

Treatment after a Thrombotic Event


Source Information

From the Department of Medicine, Section of Nephrology, University of Chicago, Chicago (J.S.L.); the Department of Obstetrics and Gynecology, University of Utah, Salt Lake City (D.W.B.); and the Department of Medicine, Division of Rheumatology, Research Institute of the McGill University Health Centre, Montreal (J.R.).

Address reprint requests to Dr. Rauch at the Montreal General Hospital Research Institute, 1650 Cedar Ave., Montreal, QC H3G 1A4, Canada, or at joyce.rauch@mcgill.ca.

References


Related Letters:

The Antiphospholipid Syndrome
Avcin T., Kveder T., Rozman B., Branch D. W., Levine J. S., Rauch J.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:145-146, Jul 11, 2002. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.